This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohas, E. A.
Right arrow Articles by Stoute, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohas, E. A.
Right arrow Articles by Stoute, J. A.

 Previous Article  |  Next Article 

Infection and Immunity, February 2004, p. 735-741, Vol. 72, No. 2
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.2.735-741.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Measurement of Antibody Levels against Region II of the Erythrocyte-Binding Antigen 175 of Plasmodium falciparum in an Area of Malaria Holoendemicity in Western Kenya{dagger}

Eunita A. Ohas,1 John H. Adams,2 John N. Waitumbi,1 Alloys S. S. Orago,3 Arnoldo Barbosa,4 David E. Lanar,4 and José A. Stoute1,5*

U.S. Army Medical Research Unit and Kenya Medical Research Institute,1 Department of Zoology, Kenyatta University, Nairobi, Kenya,3 Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana,2 Department of Immunology, Walter Reed Army Institute of Research, Silver Spring,4 Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, Maryland5

Received 20 July 2003/ Returned for modification 29 September 2003/ Accepted 27 October 2003

Region II of the 175-kDa erythrocyte-binding antigen (EBA-175RII) of Plasmodium falciparum is functionally important in sialic acid-dependent erythrocyte invasion and is considered a prime target for an invasion-blocking vaccine. The objectives of this study were to (i) determine the prevalence of anti-EBA-175RII antibodies in a naturally exposed population, (ii) determine whether naturally acquired antibodies have a functional role by inhibiting binding of EBA-175RII to erythrocytes, and (iii) determine whether antibodies against EBA-175RII correlate with immunity to clinical malaria. We treated 301 lifelong residents of an area of malaria holoendemicity in western Kenya for malaria, monitored them during a high-transmission season, and identified 33 individuals who were asymptomatic despite parasitemia (clinically immune). We also identified 50 clinically susceptible individuals to serve as controls. These 83 individuals were treated and monitored again during the subsequent low-transmission season. Anti-EBA-175RII antibodies were present in 98.7% of the individuals studied. The antibody levels were relatively stable between the beginning and end of the high-transmission season and correlated with the plasma EBA-175RII erythrocyte-binding-inhibitory activity. There was no difference in anti-EBA-175RII levels or plasma EBA-175RII erythrocyte-binding-inhibitory activity between clinically immune and clinically susceptible groups. However, these parameters were higher in nonparasitemic than in parasitemic individuals at enrollment. These results suggest that although antibodies against EBA-175RII may be effective in suppressing some of the wild parasite strains, EBA-175RII is unlikely to be effective as a monovalent vaccine against malaria, perhaps due to allelic heterogeneity and/or presence of sialic acid-independent strains.

* Corresponding author. Mailing address: Dept. of Cellular Injury, Walter Reed Army Institute of Research, 503 Robert Grant Ave., Silver Spring, MD 20910. Phone: (301) 319-9510. Fax: (301) 319-9133. E-mail: jose.stoute{at}us.army.mil.

{dagger} This work is dedicated to the memory of Eunita Ohas, a bright star whose light shined too briefly but will be missed by many colleagues and friends.

Editor: W. A. Petri, Jr.

Infection and Immunity, February 2004, p. 735-741, Vol. 72, No. 2
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.2.735-741.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Osier, F. H. A., Fegan, G., Polley, S. D., Murungi, L., Verra, F., Tetteh, K. K. A., Lowe, B., Mwangi, T., Bull, P. C., Thomas, A. W., Cavanagh, D. R., McBride, J. S., Lanar, D. E., Mackinnon, M. J., Conway, D. J., Marsh, K. (2008). Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria. Infect. Immun. 76: 2240-2248 [Abstract] [Full Text]  
  • Ford, L., Lobo, C. A., Rodriguez, M., Zalis, M. G., Machado, R. L. D., Rossit, A. R. B., Cavasini, C. E., Couto, A. A. R., Enyong, P. A., Lustigman, S. (2007). Differential Antibody Responses to Plasmodium falciparum Invasion Ligand Proteins in Individuals Living in Malaria-Endemic Areas in Brazil and Cameroon. Am J Trop Med Hyg 77: 977-983 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»